Skip to the page

Data / Form D filings / Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.: Form D filing

Faeth Therapeutics, Inc., a biotechnology company in Austin, TX, filed a Form D with the SEC in 2026. The latest, on January 27, 2026, reports $24.4 million sold of a $25 million offering to 35 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
701 TILLERY ST #12 #1010, Austin, TX, 78702
Phone
(510) 858-1839
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2100543

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 27, 2026New notice$24,999,993$24,434,214$565,77935Aug 1, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Anand ParikhExecutive Officer, Director, Promoter
Jayson DallasDirector
Oliver MaddocksExecutive Officer, Director
Robert GouldDirector
Alex MorganDirector
Stephen HahnDirector

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Jan 26, 2026 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Faeth Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.